UPau D'Arco

-Delile

• Ubufakazi obanele bokukala ukusebenza kwe ...
• Ukuqapha okukhethekile nezixwayiso:

I-Pau d'arco isihlahla esikhula ehlathini lemvula lase-Amazon nakwezinye izindawo ezishisayo zaseNingizimu naseMelika Ephakathi. Izinkuni zePau d'arco ziminyene futhi zimelana nokubola. Igama elithi "pau d'arco" ngesiPutukezi elisho "umuthi wokugoba," igama elifanele elicabanga ukusetshenziswa kwesihlahla ngabantu bomdabu baseNingizimu Melika ekwenzeni iminsalo yokuzingela. Amagxolo nezinkuni kusetshenziselwa ukwenza umuthi.

Abantu basebenzisa i-pau d'arco ngezimo ezinjengezifo, umdlavuza, isifo sikashukela, izilonda zesisu, nezinye eziningi, kepha abukho ubufakazi obuhle besayensi bokusekela lokhu kusetshenziswa. Ukusebenzisa i-pau d'arco nakho kungaphepha, ikakhulukazi kumanani aphezulu.

Imikhiqizo yezohwebo equkethe i-pau d'arco iyatholakala nge-capsule, i-tablet, i-extract, i-powder namafomu wetiye. Kepha kwesinye isikhathi kunzima ukwazi ukuthi yini emikhiqizweni yepau d'arco. Ezinye izifundo zikhombisile ukuthi eminye imikhiqizo ye-pau d'arco edayiswa eCanada, eBrazil nasePortugal ayinazo izithako ezisebenzayo ngamanani afanele.

Imibhalo Yemvelo Yemininingwane Ephelele ukukala ukusebenza ngokuncike ebufakazini besayensi ngokwesilinganiso esilandelayo: Okusebenzayo, Okungenzeka Kusebenze, Okungenzeka Kusebenze, Okungenzeka Kungasebenzi, Cishe Okungaphumeleli, Ukungasebenzi, Nobufakazi Obunganele Bokulinganisa.

Izilinganiso zokusebenza ze PAU D'ARCO zimi kanje:

Ubufakazi obanele bokukala ukusebenza kwe ...

• Ukushoda kwegazi.
• Ubuhlungu obufana ne-arthritis.
• Isifuba Somoya.
• Ukutheleleka kwesinye nesinye.
• Amathumba.
• I-bronchitis.
• Umdlavuza.
• Umkhuhlane ovamile.
• Isifo sikashukela.
• Uhudo.
• I-Eczema.
• I-Fibromyalgia.
• Umkhuhlane.
• Ukutheleleka ngemvubelo, amabhaktheriya, amagciwane, noma izimuncagazi.
• Izikelemu zesisu.
• Izinkinga zesibindi.
• I-Psoriasis.
• Izifo ezithathelwana ngocansi (i-gonorrhea, i-syphilis).
• Izinkinga zesisu.
• Ezinye izimo.

Kudingeka ubufakazi obengeziwe ukukala ukusebenza kwepau d'arco kulokhu kusetshenziswa.

Ucwaningo lwakuqala lukhombisa ukuthi i-pau d'arco ingavimbela amangqamuzana omdlavuza ukuthi angakhuli. Kunganciphisa nokukhula kwesimila ngokuvimbela isimila ekukhuleni kwemithambo yegazi edingekayo. Kodwa-ke, imithamo edingekayo ukudala imiphumela ye-anticancer ibonakala idala imiphumela emibi kakhulu ebantwini.

UPau d'arco unjalo MHLAWUMBI ANGIPHEPHILE lapho kuthathwa ngomlomo. Ngemithamo ephezulu, i-pau d’arco ingadala isicanucanu esibi, ukuhlanza, isifo sohudo, isiyezi, nokopha ngaphakathi. Ukuphepha kwepau d'arco ngemithamo ejwayelekile akwaziwa.

Ukuqapha okukhethekile nezixwayiso:

Ukukhulelwa nokuncelisa ibele: Ngesikhathi sokukhulelwa, i-pau d'arco iyi MHLAWUMBI ANGIPHEPHILE lapho ithathwa ngomlomo ngamanani ajwayelekile, futhi Cishe UNGAPHEPHILE ngemithamo emikhulu. Akwanele okwaziwayo ngokuphepha kokukufaka esikhumbeni. Hlala ohlangothini oluphephile futhi ugweme ukusetshenziswa uma ukhulelwe.

Akukho lwazi olwanele olwanele olutholakalayo mayelana nokuphepha kokuthatha i-pau d'arco uma uncelisa ibele. Hlala ohlangothini oluphephile futhi ugweme ukusetshenziswa.

Ukuhlinzwa: UPau d'arco angahle anciphise ukujiya kwegazi futhi angakhuphula amathuba okuphuma kwegazi ngesikhathi nangemva kokuhlinzwa. Yeka ukuyisebenzisa okungenani amasonto ama-2 ngaphambi kokuhlinzwa okuhleliwe.

Maphakathi

Qaphela ngale nhlanganisela.

Imithi eyehlisa ukunqamuka kwegazi (Anticoagulant / Antiplatelet drug)

UPau d'arco angahle anciphise ukujiya kwegazi. Ukuthatha i-pau d'arco kanye nemithi nayo ejija kancane ukuvimba kungandisa amathuba okulimala nokopha.

Eminye imishanguzo eyehlisa ijubane ukuvala igazi ifaka phakathi i-aspirin, i-clopidogrel (i-Plavix), i-diclofenac (i-Voltaren, i-Cataflam, abanye), i-ibuprofen (i-Advil, i-Motrin, abanye), i-naproxen (i-Anaprox, i-Naprosyn, abanye), i-dalteparin (i-Fragmin), i-enoxaparin (i-Lovenox) , heparin, warfarin (Coumadin), nabanye.

Amakhambi nezengezo ezinganciphisa ukujiya kwegazi

UPau d'arco angahle anciphise ukujiya kwegazi. Ukuthatha i-pau d'arco kanye namanye amakhambi noma izithasiselo nazo eziqinisa ukunqamuka kungandisa amathuba okulimala nokopha kwabanye abantu. Lawa makhambi afaka i-alfalfa, i-angelica, i-clove, i-danshen, i-chestnut yamahhashi, i-red clover, i-turmeric, namanye.

Akukho ukuxhumana okwaziwayo nokudla.

Umthamo ofanele we-pau d'arco uncike ezicini eziningana ezifana nobudala bomsebenzisi, impilo, kanye nezinye izimo eziningana. Ngalesi sikhathi alukho ulwazi olwanele lwesayensi ukunquma uhla olufanele lwamanani we-pau d'arco. Khumbula ukuthi imikhiqizo yemvelo ayihlali iphephile njalo futhi imithamo ingabaluleka. Qiniseka ukuthi ulandela izinkomba ezifanele kumalebula womkhiqizo futhi uthintane nosokhemisi wakho noma udokotela noma omunye uchwepheshe wezokunakekelwa kwempilo ngaphambi kokusebenzisa.

Ébénier de Guyane, Ébène Vert, Handroanthus impetiginosus, Ipe, Ipe Roxo, Ipes, Lapacho, Lapacho Colorado, Lapacho Morado, Lapacho Negro, Lébène, Pink Trumpet Tree, Purple Lapacho, Quebracho, Red Lapacho, Tabebuia avellanosae, Tabebuia avellanosae, , Tabebuia palmeri, Taheebo, Taheebo Tea, Tecoma impetiginosa, Thé Taheebo, Trumpet Bush.

Ukuze ufunde kabanzi ngokuthi le ndatshana ibhalwe kanjani, sicela ubheke ifayela le- Imibhalo Yemvelo Yemininingwane Ephelele indlela.

1. I-Algranti E, i-Mendonça EM, i-Ali SA, i-Kokron CM, i-Raile V. I-asthma yasemsebenzini ebangelwa uthuli lwe-Ipe (Tabebuia spp). UJ Investig Allergol Clin Immunol 2005; 15: 81-3. Buka okungaqondakali.
2. UZhang L, Hasegawa I, Ohta T. Ama-anti-inflammatory cyclopentene avela kokukhonkotha kwangaphakathi kweTabebuia avellanedae. UFitoterapia 2016; 109: 217-23. Buka okungaqondakali.
3. U-Lee S, Kim IS, Kwak TH, Yoo HH. Ucwaningo lokuqhathanisa lwe-metabolism lwe-ß-lapachone kumagundane, i-rat, inja, inkawu, kanye nama-microsomes wesibindi somuntu kusetshenziswa i-liquid chromatography-tandem mass spectrometry. UJ Pharm Biomed Anal 2013; 83: 286-92. Buka okungaqondakali.
4. UHussain H, uKrohn K, Ahmad VU, et al. I-Lapachol: ukubuka konke. I-Arkivok 2007 (ii): 145-71.
5. IPereira IT, uBurci LM, da Silva LM, et al. Umphumela we-antiulcer wokukhishwa kwe-bark weTabebuia avellanedae: ukwenziwa kwesibindi kwandiswe ku-mucosa yesisu ngesikhathi sokuphulukiswa. I-Phytother Res 2013; 27: 1067-73. Buka okungaqondakali.
6. UMacedo L, uFernandes T, uSilveira L, et al. Umsebenzi we-ß-Lapachone ekusebenzisaneni nama-antimicrobial ajwayelekile emelana nezinkinga ze-methicillin ezingamelana ne-Staphylococcus aureus. I-Phytomedicine 2013; 21: 25-9. Buka okungaqondakali.
7. UPires TC, uDias MI, uCalhelha RC, et al. Izakhiwo ze-bioactive zeTabebuia impetiginosa-based phytopreparations and phytoformulations: ukuqhathanisa phakathi kokukhishwa nezithako zokudla. Amamolekyuli 2015; 1; 20: 22863-71. Buka okungaqondakali.
8. Thola i-DVC. I-taheebo yokuhweba ayinaso isithako esisebenzayo. Incwadi Yemininingwane 726 Can Pharm J. 1991; 121: 323-26.
9. I-Awang DVC, iDawson BA, i-Ethier JC, et al. INaphthoquinone Constituents of Commercial Lapacho / Pau d'arco / Taheebo Products. Izitshalo zeJ Herbs Spic Med. 1995; 2: 27-43.
10. I-Nepomuceno JC. ILapachol kanye nokuphuma kwayo njengezidakamizwa ezingaba khona zokwelashwa komdlavuza. Ku: Izitshalo Nesilimo - Ucwaningo lweBiology neBiotechnology, umhla ka-1 ku-ed. IConcept Press Ltd .. Ibuyiswe kusuka: https://www.researchgate.net/profile/Julio_Nepomuceno/publication/268378689_Lapachol_and_its_derivatives_as_potential_drugs_for_cancer_treatment/links/5469c8640cf20dedafd103e1.pdf
11. Ama-Paes JB, Morais VM, Lima CR. Resistência natural de nove madeiras do semi-árido brasileiro a fungos causadores da podridão-mole. R. Árvore, 2005; 29: 365-71.
12. UKreher B, uLotter H, uCordell GA, uWagner H. New Furanonaphthoquinones namanye amaConstituent aseTabebuia avellanedae kanye ne-Immunomodulating Activities in vitro. UPlanta Med. 1988; 54: 562-3. Buka okungaqondakali.
13. de Almeida ER, da Silva Filho AA, dos Santos ER, Lopes CA. Isenzo sokulwa nokuvuvukala se-lapachol. J Ethnopharmacol. 1990; 29: 239-41. Buka okungaqondakali.
14. UGuiraud P, uSteiman R, uCampos-Takaki GM, uSeigle-Murandi F, uSimeon de Buochberg M. Ukuqhathaniswa kwemisebenzi elwa namagciwane kanye ne-antifungal ye-lapachol ne-beta-lapachone. UPlanta Med. 1994; 60: 373-4. Buka okungaqondakali.
15. Vimba i-JB, i-Serpick AA, i-Miller W, i-Wiernik PH. Izifundo zokuqala zokwelashwa nge-lapachol (NSC-11905). I-Cancer Chemother Rep 2. 1974; 4: 27-8. Buka okungaqondakali.
16. UKung, H. N., Yang, M. J., Chang, C. F., Chau, Y. P., noLu, K. S. In vitro kanye naku-vivo imisebenzi yokupholisa amanxeba okukhuthaza i-beta-lapachone. NginguJ. J Physiol Cell Physiol 2008; 295: C931-C943. Buka okungaqondakali.
17. UByeon, S. E., Chung, J. Y., Lee, Y. G., Kim, B. H., Kim, K. H., noCho, J. Y. In vitro kanye ne-vivo imiphumela elwa nokuvuvukala kwe-taheebo, okukhishwa emanzini kusuka kugxolo lwangaphakathi lweTabebuia avellanedae. J Ethnopharmacol. 9-2-2008; 119: 145-152. Buka okungaqondakali.
18. I-Twardowschy, A., Freitas, CS, Baggio, CH, Mayer, B., dos Santos, AC, Pizzolatti, MG, Zacarias, AA, dos Santos, EP, Otuki, MF, neMarques, umsebenzi we-MC Antiulcerogenic wegxolo elikhishwe UTabebuia avellanedae, uLorentz ex Griseb. J Ethnopharmacol. 8-13-2008; 118: 455-459. Buka okungaqondakali.
19. I-Queiroz, ML, Valadares, MC, Torello, CO, Ramos, AL, Oliveira, AB, Rocha, FD, Arruda, VA, ne-Accorci, WR Ucwaningo lokuqhathanisa ngemiphumela yeThabuia avellanedae bark extract kanye ne-beta-lapachone empendulweni ye-hematopoietic amagundane athwala isimila. J Ethnopharmacol. 5-8-2008; 117: 228-235. Buka okungaqondakali.
20. I-Savage, i-RE, i-Tyler, i-AN, i-Miao, i-XS, ne-Chan, i-TC Ukukhonjwa kwe-glucosylsulfate conjugate yenoveli njenge-metabolite ye-3,4-dihydro-2,2-dimethyl-2H-naphtho [1,2-b] pyran- I-5,6-dione (ARQ 501, i-beta-lapachone) ezilwaneni ezincelisayo. Izidakamizwa zeMetab Yezidakamizwa. 2008; 36: 753-758. Buka okungaqondakali.
21. Yamashita, M., Kaneko, M., Iida, A., Tokuda, H., noNishimura, K. Stereoselective synthesis kanye ne-cytotoxicity yomdlavuza we-chemopreventive naphthoquinone ovela eTabebuia avellanedae. I-Medio Chem.Let. 12-1-2007; 17: 6417-6420. Buka okungaqondakali.
22. UKim, S. O., Kwon, J. I., Jeong, Y. K., Kim, G. Y., Kim, N. D., noChoi, Y.H.Ukufakwa kwe-Egr-1 kuhlotshaniswa namandla we-beta-lapachone kumaseli womuntu we-hepatocarcinoma. I-Biosci Biotechnol Biochem 2007; 71: 2169-2176. Buka okungaqondakali.
23. de Cassia da Silveira E Sa no-Oliveira, Guerra M. Ubuthi bokuzala be-lapachol kumagundane amadala aseWistar athunyelwe ekwelashweni kwesikhashana. I-Phytother.Res. 2007; 21: 658-662. Buka okungaqondakali.
24. Kung, H. N., Chien, C. L., Chau, G. Y., Don, M. J., Lu, K. S., no Chau, Y. P. Ukubandakanywa kwe-NO / cGMP ukusayina emiphumeleni ye-apoptotic kanye ne-anti-angiogenic ye-beta-lapachone kumaseli endothelial e-vitro. UJ Iseli Physiol 2007; 211: 522-532. Buka okungaqondakali.
25. I-Woo, HJ, Park, KY, Rhu, CH, Lee, WH, Choi, BT, Kim, GY, Park, YM, noChoi, YH Beta-lapachone, i-quinone ehlukaniswe neTabebuia avellanedae, idala i-apoptosis ku-HepG2 hepatoma cell line ngokungeniswa kwe-Bax nokwenza kusebenze i-caspase. J Med Ukudla 2006; 9: 161-168. Buka okungaqondakali.
26. Indodana, DJ, Lim, Y., Ipaki, YH, Chang, SK, Yun, YP, Hong, JT, Takeoka, GR, Lee, KG, Lee, SE, Kim, MR, Kim, JH, and Park, BS Inhibitory imiphumela ye-Tabebuia impetiginosa bark yangaphakathi ekhishwe ku-platelet aggregation naku-vascular smooth muscle cell proliferation ngokusebenzisa ukucindezelwa kwe-arachidonic acid liberation kanye ne-ERK1 / 2 MAPK activation. J Ethnopharmacol. 11-3-2006; 108: 148-151. Buka okungaqondakali.
27. U-Lee, JI, Choi, DY, Chung, HS, Seo, HG, Woo, HJ, Choi, BT, noChoi, YH beta-lapachone bakhuthaza ukuvinjelwa kokukhula kanye ne-apoptosis kumaseli womdlavuza wesinye ngokushintshashintsha komndeni we-Bcl-2 nokwenza kusebenze amacaspase. Exp.Oncol. 2006; 28: 30-35. Buka okungaqondakali.
28. UPereira, EM, Machado, Tde B., Leal, IC, Jesus, DM, Damaso, CR, Pinto, AV, Giambiagi-deMarval, M., Kuster, RM, neSantos, KR Tabebuia avellanedae naphthoquinones: umsebenzi ophikisana nemethicillin-resistant izingqinamba ze-staphylococcal, umsebenzi we-cytotoxic kanye naku-vivo dermal irritability analysis. I-Ann.Clin.Microbiol.Imithi elwa namagciwane. 2006; 5: 5. Buka okungaqondakali.
29. UFelicio, A. C., Chang, C. V., Brandao, M. A., Peters, V. M., noGuerra, Mde O. Ukukhula kwe-Fetal kumagundane aphathwe nge-lapachol. Ukuvimbela ukukhulelwa 2002; 66: 289-293. Buka okungaqondakali.
30. UGuerra, Mde O., Mazoni, A. S., Brandao, M. A., noPeter, V. M. Toxicology weLapachol kumagundane: umbungu wokutholwa. UBraz. J Biol. 2001; 61: 171-174. Buka okungaqondakali.
31. ILemos OA, iSanches JC, uSilva IE, et al. Imiphumela yeGenotoxic yeTabebuia impetiginosa (Mart. Ex DC.) Standl. (Lamiales, Bignoniaceae) kukhishwe amagundane eWistar. IGenet Mol Biol 2012; 35: 498-502. Buka okungaqondakali.
32. IKiage-Mokua BN, Roos N, Schrezenmeir J. Lapacho Tea (Tabebuia impetiginosa) Extract Inhibits Pancreatic Lipase and Delays Postprandial Triglyceride Ukwanda Kwamagundane. I-Phytother Res 2012 Mar 17. i-doi: 10.1002 / ptr.4659. Buka okungaqondakali.
33. de Melo JG, Santos AG, de Amorim EL, et al. Izitshalo zokwelapha ezisetshenziswa njengama-antitumor agents eBrazil: indlela ethnobotanical. I-Evid Based Complement Alternat Med 2011; 2011: 365359. I-Epub 2011 Mar 8. Buka okungaqondakali.
34. UGómez Castellanos JR, Prieto JM, Heinrich M. Red Lapacho (Tabebuia impetiginosa) - umkhiqizo wezinto zomhlaba wonke we-ethnopharmacological? UJ Ethnopharmacol 2009; 121: 1-13. Buka okungaqondakali.
35. IPark BS, uLee HK, uLee SE, et al. Umsebenzi we-Antibacterial weTabebuia impetiginosa Martius ex DC (Taheebo) ngokumelene noHelicobacter pylori. UJ Ethnopharmacol 2006; 105: 255-62. Buka okungaqondakali.
36. IPark BS, uKim JR, uLee SE, et al. Imiphumela yokukhetha ukukhula-yokuvimbela yamakhemikhali akhonjwe ku-Tabebuia impetiginosa bark yangaphakathi kumagciwane wamathumbu womuntu. J Agric Ukudla Chem 2005; 53: 1152-7. Buka okungaqondakali.
37. UKoyama J, Morita I, Tagahara K, Hirai K. Cyclopentene dialdehydes waseTabebuia impetiginosa. I-Phytochemistry 2000; 53: 869-72. Buka okungaqondakali.
38. IPark BS, uLee KG, uShibamoto T, et al. Umsebenzi we-antioxidant kanye nokuchazwa kwezakhi eziguqukayo zeTaheebo (Tabebuia impetiginosa Martius ex DC). J Agric Ukudla Chem 2003; 51: 295-300. Buka okungaqondakali.

Kugcine ukubuyekezwa - 08/16/2018